Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Vida

- PMLiVE

Digital’s ever-changing display of ideas

Creating a coherent strategy to bridge the divide between digital and other elements of the marketing mix.

- PMLiVE

Novo Nordisk invests £115m in Oxford diabetes unit

But Danish pharma company admitted Brexit had made it a harder decision

- PMLiVE

Millennials and health

Why the pharma industry has to reinvent itself to engage with the millennial generation

The rating game

Have we gone too far with online healthcare reviews?

- PMLiVE

2017 Trends Reports

GSW and InVentiv Health Communications are pleased to release the 6th installment of the Trends report series, consisting of four reports: Consumer, Digital, Communications and Healthcare

Syneos Health®

- PMLiVE

NICE U-turn on Imbruvica sees the leukaemia therapy backed for NHS use

Institute reverses its initial verdict on Janssen's oncology treatment

- PMLiVE

The reality of real-world evidence

Despite a slow uptake of RWE, there is an increasing trend in the use of healthcare system data to inform clinical practice

- PMLiVE

The digital race: Eight ways to get up-to-speed

The festive season is over, so why does analysis of pharma’s digital progress feel like a Christmas repeat of Groundhog Day? Here are eight ideas to stop next year feeling like...

- PMLiVE

Real-world evidence

Companies are now recruiting high-level executives to lead well-resourced RWE teams as industry looks to reshape the future

- PMLiVE

Is print the new vinyl?

The release of the National Medical Readership Survey prompts the inevitable discussion about the role of print vs. other channels in the marketing mix, when targeting GPs and HCPs generally...

UK flag

May says UK’s science base is a “negotiating priority” for Brexit

Stokes confidence in UK pharma as science and innovation featured among 12 key priorities

Market access in Europe: balancing access and affordability

European governments continue to pursue national agendas for market access, while also exploring opportunities to work together to achieve lower prices for new drugs

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links